BLLN BillionToOne, Inc.

NASDAQ
$102.73

BillionToOne, Inc. (BLLN) is confirmed to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is $0.16 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.3% since its last earnings release on August 5, 2026.

BillionToOne Reported In-line with Estimates, Reaffirms
Wednesday, August 5, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs $0.16
Rev est $116.23M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $100.19

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BillionToOne, Inc.

BillionToOne is a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all.

Sector

Healthcare

Industry

Medical Labs & Research

Charts powered in part by Lightweight Charts™ by TradingView.